Clinical Trial Results:
SINGLE-BLIND RANDOMIZED CONTROLLED PHASE II/III STUDY TO INVESTIGATE THE IMMUNOGENICITY AND SAFETY AFTER A SINGLE VACCINATION WITH ONE OF THREE DIFFERENT LOTS OF AN INACTIVATED INFLUENZA VACCINE (WHOLE VIRION, VERO CELL- DERIVED) IN COMPARISON TO A LICENSED EGG DERIVED INFLUENZA VACCINE FOR SEASON 2004/2005
Summary
|
|
EudraCT number |
2004-001374-34 |
Trial protocol |
AT GB |
Global completion date |
29 Jul 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Jun 2019
|
First version publication date |
15 Jun 2019
|
Other versions |
|
Summary report(s) |
2004-001374-34 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.